|
1
|
Mao A: Interventional therapy of
Esophageal Cancer. Gastrointest Tumors. 3:59–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shaib WL, Nammour JP, Gill H, Mody M and
Saba NF: The future prospects of immune therapy in gastric and
esophageal adenocarcinoma. J Clin Med. 5(pii): E1002016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang K, Wu X, Wang J, Lopez J, Zhou W,
Yang L, Wang SE, Raz DJ and Kim JY: Circulating miRNA profile in
esophageal adenocarcinoma. Am J Cancer Res. 6:2713–2721.
2016.PubMed/NCBI
|
|
4
|
Malhotra A, Sharma U, Puhan S, Chandra
Bandari N, Kharab A, Arifa PP, Thakur L, Prakash H, Vasquez KM and
Jain A: Stabilization of miRNAs in esophageal cancer contributes to
radioresistance and limits efficacy of therapy. Biochimie.
156:148–157. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jamali L, Tofigh R, Tutunchi S, Panahi G,
Borhani F, Akhavan S, Nourmohammadi P, Ghaderian SMH, Rasouli M and
Mirzaei H: Circulating microRNAs as diagnostic and therapeutic
biomarkers in gastric and esophageal cancer. J Cell Physiol.
233:8538–8550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou HQ, Chen QC, Qiu ZT, Tan WL, Mo CQ
and Gao SW: Integrative microRNA-mRNA and protein-protein
interaction analysis in pancreatic neuroendocrine tumors. Eur Rev
Med Pharmacol Sci. 20:2842–2852. 2016.PubMed/NCBI
|
|
8
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xuan Y, Yang H, Zhao L, Lau WB, Lau B, Ren
N, Hu Y, Yi T, Zhao X, Zhou S and Wei Y: MicroRNAs in colorectal
cancer: Small molecules with big functions. Cancer Lett.
360:89–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen S, Chen X, Xiu YL, Sun KX and Zhao Y:
MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial
carcinoma tumorigenesis and progression. Cancer Lett. 362:122–130.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen J, Xiao Z, Wu WK, Wang MH, To KF,
Chen Y, Yang W, Li MS, Shin VY, Tong JH, et al: Epigenetic
silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1
to promote Helicobacter pylori-induced gastric carcinogenesis.
Cancer Res. 75:754–765. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li W, Guo F, Wang P, Hong S and Zhang C:
MiR-221/222 confers radioresistance in glioblastoma cells through
activating Akt independent of PTEN status. Curr Mol Med.
14:185–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang LY, Liu M, Li X and Tang H:
MiR-490-3p modulates cell growth and epithelial to mesenchymal
transition of hepatocellular carcinoma cells by targeting
endoplasmic reticulum-Golgi intermediate compartment protein 3
(ERGIC3). J Biol Chem. 288:4035–4047. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu W, Xu G, Liu H and Li T:
MicroRNA-490-3p regulates cell proliferation and apoptosis by
targeting HMGA2 in osteosarcoma. FEBS Lett. 589:3148–3153. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tian J, Xu YY, Li L and Hao Q: MiR-490-3p
sensitizes ovarian cancer cells to cisplatin by directly targeting
ABCC2. Am J Transl Res. 9:1127–1138. 2017.PubMed/NCBI
|
|
16
|
Li S, Xu X, Xu X, Hu Z, Wu J, Zhu Y, Chen
H, Mao Y, Lin Y, Luo J, et al: MicroRNA-490-5p inhibits
proliferation of bladder cancer by targeting c-Fos. Biochem Biophys
Res Commun. 441:976–981. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rezatabar S, Karimian A, Rameshknia V,
Parsian H, Majidinia M, Kopi TA, Bishayee A, Sadeghinia A, Yousefi
M, Monirialamdari M and Yousefi B: RAS/MAPK signaling functions in
oxidative stress, DNA damage response and cancer progression. J
Cell Physiol. Feb 27–2019;doi: 10.1002/jcp.28334 (Epub ahead of
print). PubMed/NCBI
|
|
18
|
Krysan PJ and Colcombet J: Cellular
complexity in MAPK signaling in plants: Questions and emerging
tools to answer them. Front Plant Sci. 9:16742018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chatterjee N, Das S, Bose D, Banerjee S,
Jha T and Das Saha K: Lipid from infective L. Donovani regulates
acute myeloid cell growth via mitochondria dependent MAPK pathway.
PLoS One. 10:e1205092015. View Article : Google Scholar
|
|
20
|
Chen SX, Zhao F and Huang XJ: MAPK
signaling pathway and erectile dysfunction. Zhonghua Nan Ke Xue.
24:442–446. 2018.(In Chinese). PubMed/NCBI
|
|
21
|
Furukawa T: Impacts of activation of the
mitogen-activated protein kinase pathway in pancreatic cancer.
Front Oncol. 5:232015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hummel R, Sie C, Watson DI, Wang T, Ansar
A, Michael MZ, Van der Hoek M, Haier J and Hussey DJ: MicroRNA
signatures in chemotherapy resistant esophageal cancer cell lines.
World J Gastroenterol. 20:14904–14912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shah AA, Leidinger P, Backes C, Keller A,
Karpinski P, Sasiadek MM, Blin N and Meese E: A set of specific
miRNAs is connected with murine and human gastric cancer. Genes
Chromosomes Cancer. 52:237–249. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang LL, Sun KX, Wu DD, Xiu YL, Chen X,
Chen S, Zong ZH, Sang XB, Liu Y and Zhao Y: DLEU1 contributes to
ovarian carcinoma tumourigenesis and development by interacting
with miR-490-3p and altering CDK1 expression. J Cell Mol Med.
21:3055–3065. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu J, Pan X and Hu Z: MiR-502 mediates
esophageal cancer cell TE1 proliferation by promoting AKT
phosphorylation. Biochem Biophys Res Commun. 501:119–123. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang N, Song X, Xie J, Xu D, Liu F, Yu X,
Tian Y, Liu Z, Qiao L and Zhang J: Effect of galectin-3 on the
behavior of Eca109 human esophageal cancer cells. Mol Med Rep.
11:896–902. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kim EK and Choi EJ: Compromised MAPK
signaling in human diseases: An update. Arch Toxicol. 89:867–882.
2015. View Article : Google Scholar : PubMed/NCBI
|
